跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分66

FDA 执法报告 D-0150-2027:Victory Medical Center Pharmacy 替尔泊肽/左卡尼汀因缺乏工艺控制被定 II 类召回

FDA drug enforcement D-0150-2027: Victory Medical Center Pharmacy — Lack of Processing Controls

AI 导读

FDA 执法报告 D-0150-2027 记录 Victory Medical Center Pharmacy(得州奥斯汀)的替尔泊肽/左卡尼汀 25/50mg/mL 3mL 多剂量瓶产品因缺乏工艺控制被定为 II 类召回。

推荐理由

该执法报告记录替尔泊肽/左卡尼汀产品因缺乏工艺控制被定为 II 类召回,可核对三个批号与分销州范围。

正文 · 原文

FDA drug recall enforcement report — D-0150-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "4303 Victory Dr",

"address_2": "",

"center_classification_date": "20261030",

"city": "Austin",

"classification": "Class II",

"code_info": "Lot, expiry: Lot 2053172 , exp 10/24/2026; Lot 2028876 , exp 10/27/2026; Lot 2060129 , exp 11/3/2026",

"country": "United States",

"distribution_pattern": "CO, FL, TX",

"event_id": "100168",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {},

"postal_code": "78704-7507",

"product_description": "TIRZEPATIDE/L-CARNITINE (MDV) 25/50MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas",

"product_quantity": "343 vials",

"product_type": "Drugs",

"reason_for_recall": "Lack of Processing Controls",

"recall_initiation_date": "20261019",

"recall_number": "D-0150-2027",

"recalling_firm": "Victory Medical Center Pharmacy",

"report_date": "20261111",

"state": "TX",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov